DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

References

Kaneko M, Tanigawa T, Hashizume K, Kajikawa M, Tajiri M, Mueck W.
Confirmation of model-based dose selection for a Japanese phase III study of rivaroxaban in non-valvular atrial fibrillation patients.

Drug Metab Pharmacokinet 2013;
28 (04) 321-331

Download Bibliographical Data

Access:
Access: